Angiotensin II Type 2 Receptor–interacting Protein 3a Inhibits Ovarian Carcinoma Metastasis via the Extracellular HMGA2-mediated ERK/EMT Pathway

Tumor Biology - United States
doi 10.1177/1010428317713389
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Overexpression of HMGA2 Promotes Tongue Cancer Metastasis Through EMT Pathway

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer in Vivo

Journal of Cancer
Oncology
2016English

Propofol Inhibits Hepatocellular Carcinoma Growth and Invasion Through the HMGA2-mediated WNT/Β-Catenin Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/No System and Inhibits Fibrosis

Hypertension
Internal Medicine
2003English

The Angiotensin II Type 2 Receptor in the Brain

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2009English

Differential Kinetic and Spatial Patterns of Β-Arrestin and G Protein-Mediated ERK Activation by the Angiotensin II Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Macrophage Angiotensin II Type 2 Receptor Triggers Neuropathic Pain

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway

PLoS ONE
Multidisciplinary
2013English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy